肺泡灌洗液肝素结合蛋白、白细胞介素-17A水平预测老年重症肺炎患者预后的价值

Value of heparin-binding protein and interleukin-17A levels in bronchoalveolar lavage fluid in predicting prognosis of elderly patients with severe pneumonia

  • 摘要:
    目的 分析肺泡灌洗液肝素结合蛋白(HBP)、白细胞介素-17A(IL-17A)水平预测老年重症肺炎患者预后的价值。
    方法 选取本院2022年5月—2024年5月收治的105例老年重症肺炎患者,根据入院28 d内生存结局分为死亡组32例和生存组73例。比较2组肺泡灌洗液HBP、IL-17A水平; 采用Logistic回归分析探讨老年重症肺炎患者预后的影响因素; 绘制受试者工作特征(ROC)曲线,分析肺泡灌洗液HBP、IL-17A对老年重症肺炎患者预后的预测效能。
    结果 死亡组肺泡灌洗液HBP、IL-17A水平高于生存组,差异有统计学意义(P < 0.01)。2组急性生理功能和慢性健康状况评分系统Ⅱ(APACHE Ⅱ)评分、血乳酸(Lac)比较,差异有统计学意义(P < 0.01)。Logistic回归分析显示, HBP(OR=3.084, 95%CI: 1.326~4.694)、IL-17A(OR=4.521, 95%CI: 2.164~7.841)、APACHE Ⅱ评分(OR=2.039, 95%CI: 1.069~2.859)、Lac(OR=2.627, 95%CI: 1.168~3.058)是老年重症肺炎患者预后的影响因素(P < 0.05)。HBP最佳临界值取15.92 ng/mL、IL-17A最佳临界值取109.34 pg/mL时,肺泡灌洗液HBP、IL-17A联合预测老年重症肺炎患者预后的曲线下面积(AUC)为0.852, 95%CI为0.801~0.948, 肺泡灌洗液HBP、IL-17A联合预测老年重症肺炎患者预后的AUC高于单一检测(Z=2.906、2.416, P=0.007、0.014)。
    结论 肺泡灌洗液HBP、IL-17A增高, APACHE Ⅱ评分降低,以及Lac增高是老年重症肺炎患者预后的影响因素,联合检测肺泡灌洗液HBP、IL-17A在预测老年重症肺炎患者预后方面的灵敏度较高。

     

    Abstract:
    Objective To analyze the value of heparin-binding protein (HBP) and interleukin-17A (IL-17A) levels in bronchoalveolar lavage fluid in predicting prognosis of elderly patients with severe pneumonia.
    Methods A total of 105 elderly patients with severe pneumonia in the hospital from May 2022 to May 2024 were selected and divided into death group (n=32) and survival group (n=73) based on their survival outcomes within 28 days after admission. The levels of HBP and IL-17A in bronchoalveolar lavage fluid were compared between the two groups; the Logistic regression analysis was conducted to explore the influencing factors for prognosis in elderly patients with severe pneumonia; the receiver operating characteristic (ROC) curve was plotted to analyze the predictive efficiencies of HBP and IL-17A in bronchoalveolar lavage fluid for the prognosis of elderly patients with severe pneumonia.
    Results The levels of HBP and IL-17A in bronchoalveolar lavage fluid in the death group were significantly higher than those in the survival group (P < 0.01). There were significant differences in the Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) score and blood lactate (Lac) level between the two groups (P < 0.01). Logistic regression analysis showed that HBP (OR=3.084, 95%CI, 1.326 to 4.694), IL-17A (OR=4.521, 95%CI, 2.164 to 7.841), APACHE Ⅱ score (OR=2.039, 95%CI, 1.069 to 2.859), and Lac (OR=2.627, 95%CI, 1.168 to 3.058) were influencing factors for the prognosis of elderly patients with severe pneumonia (P < 0.05). When the optimal cut-off values were set at 15.92 ng/mL for HBP and 109.34 pg/mL for IL-17A, the area under the curve (AUC) for the combined prediction of prognosis by HBP and IL-17A in bronchoalveolar lavage fluid was 0.852, with a 95%CI of 0.801 to 0.948. The AUC for the combined prediction of prognosis by HBP and IL-17A in bronchoalveolar lavage fluid was significantly higher than that for single tests (Z=2.906, 2.416, P=0.007, 0.014).
    Conclusion Increased levels of HBP and IL-17A in bronchoalveolar lavage fluid, decreased APACHE Ⅱ score, and increased Lac are influencing factors for the prognosis of elderly patients with severe pneumonia. Combined detection of HBP and IL-17A in bronchoalveolar lavage fluid has high sensitivity in predicting the prognosis of elderly patients with severe pneumonia.

     

/

返回文章
返回